Stay updated on Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page.

Latest updates to the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows Revision: v3.4.2 and no longer displays Revision: v3.4.1, indicating a minor site version update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 removed. This appears to be an administrative version update that does not alter study details or navigation on the page.SummaryDifference0.0%

- Check29 days agoChange DetectedAdded a 'Show glossary' option and minor metadata/label updates (e.g., 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', 'Revision: v3.4.0'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedRevision note updated: Revision v3.3.4 has been added and Revision v3.3.3 has been removed.SummaryDifference0.0%

- Check65 days agoChange DetectedA consolidated Locations section lists all site locations by state and the revision shows v3.3.3. Individual state location subsections (e.g., California Locations, Colorado Locations) were removed.SummaryDifference2%

- Check86 days agoChange DetectedThe page footer revision label was updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page.